-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Ribavirin-[13C5]
Category | SARS-CoV |
CAS | 1646818-35-0 |
Description | Ribavirin-[13C5] is the labelled analogue of Ribavirin. Ribavirin is an anti-viral medication used to treat RSV infection, hepatitis C, and viral hemorrhagic fever. |
Product Information
Synonyms | [13C5]-Ribavirin; 1-β-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide-13C5; Copegus-13C5; ICN 1229-13C5; MegaRibavirin-13C5; NSC 163039-13C5; Ravanex-13C5; Rebetol-13C5; Ribamide-13C5; Ribamidil-13C5; Ribasphere-13C5; Ribavarin-13C5; Tribavirin-13C5; Vilona-13C5; Viramid-13C5; Virazole-13C5; Virizadole-13C5 |
IUPAC Name | 1-[(2R,4R,5R)-3,4-dihydroxy-5-(hydroxy(1-13C)methyl)(2,3,4,5-13C4)oxolan-2-yl]-1,2,4-triazole-3-carboxamide |
Molecular Weight | 249.17 |
Molecular Formula | C3[13C]5H12N4O5 |
Canonical SMILES | C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N |
InChI | InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4+,5?,8-/m1/s1/i1+1,3+1,4+1,5+1,8+1 |
InChIKey | IWUCXVSUMQZMFG-GOZXRHHJSA-N |
Melting Point | 160-162°C |
Purity | 95%; > 98% atom 13C |
Solubility | Slightly soluble in DMSO, Methanol, Water |
Appearance | Off-White to Pale Yellow Solid |
Storage | -20 °C under inert atmosphere |
Complexity | 304 |
Exact Mass | 249.09754367 |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
Target | HCV; RSV; Antibiotic |
XLogP3-AA | -1.8 |